Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM: Comparison With CMR T1-Mapping And Histology in a Rabbit Model
Overview
Radiology
Authors
Affiliations
Objectives: This study sought to evaluate whether patterns of myocardial change in doxorubicin-induced dilated cardiomyopathy determined using dual-energy computed tomography (CT) were similar to characterization by extracellular volume fraction (ECV) using cardiac magnetic resonance (CMR) T1-mapping and collagen volume fraction (CVF) measured using histology.
Background: Anthracycline chemoagents are effective against a wide range of malignant conditions. However, cardiotoxicity is a well-known adverse effect of these drugs. Dual-energy CT could be as useful as magnetic resonance (MR) to evaluate myocardial change in anthracycline-induced cardiotoxicity.
Methods: A dilated cardiomyopathy rabbit model was generated by injecting 11 adult New Zealand rabbits with 1.0 mg/kg of doxorubicin twice weekly for 16 weeks. Contrast-enhanced dual-energy CT and pre-contrast and post-contrast T1-mapping CMR using a prototype modified Look-Locker inversion recovery on a clinical 3-T scanner were performed on 15 rabbits, including 4 control animals, to calculate ECV at baseline, and at 6, 12, and 16 weeks after doxorubicin administration.
Results: The mean ECV values (%) on CT and CMR at 6, 12, and 16 weeks after modeling were significantly higher than those measured at baseline (CT ECV: 35.3%, 41.9%, 42.1% vs. 28.5%; MR ECV: 32.6%, 35.8%, 41.3% vs. 28.8%, respectively; all p < 0.001). CT ECV and MR ECV values were well correlated (r = 0.888; p < 0.001). Both were well correlated with CVF on histology (CT ECV vs. CVF, r = 0.925, p < 0.001 and MR ECV vs. CVF, r = 0.961, p < 0.001, respectively).
Conclusions: Dual-energy CT ECV correlated well with CMR and histology. Dual-energy CT is useful for characterizing doxorubicin-induced cardiomyopathy by measuring ECV fraction; however, further technical improvements are desirable to lower motion artifact and improve image quality of the iodine map.
Wu H, Huang Y, Yang M, Lu Z, Deng W, Wang Y Quant Imaging Med Surg. 2025; 15(1):404-416.
PMID: 39839008 PMC: 11744108. DOI: 10.21037/qims-24-777.
Chen Y, Shen Y, Zhang H, Wang X, Xu Y, Zhang J Rev Cardiovasc Med. 2024; 25(2):62.
PMID: 39077361 PMC: 11263182. DOI: 10.31083/j.rcm2502062.
Li N, Wang J, Wang X, Zha L Int J Med Sci. 2024; 21(9):1769-1782.
PMID: 39006834 PMC: 11241094. DOI: 10.7150/ijms.92537.
Cardiac computed tomography with late contrast enhancement: A review.
Tore D, Faletti R, Palmisano A, Salto S, Rocco K, Santonocito A Heliyon. 2024; 10(11):e32436.
PMID: 38933964 PMC: 11200357. DOI: 10.1016/j.heliyon.2024.e32436.
Hu Y, Ma P, Chen L, Liu J, Shang Y, Jian W Heliyon. 2023; 9(11):e21845.
PMID: 38058655 PMC: 10695840. DOI: 10.1016/j.heliyon.2023.e21845.